We have identified a Xenopus cDNA, XS-2, by screening a Xenopus embryonic stage-22-24 cDNA library with a DNA probe encoding the transmembrane and cytoplasmic domains of mouse syndecan 1. The 1.4 kb cDNA consists of an open reading frame of 642 nucleotides encoding a protein of 191 amino acids. The predicted protein of 20869 Da contains a 25-amino acid putative transmembrane domain and a 32-amino acid putative cytoplasmic domain, both of which are highly similar to the corresponding regions of rat syndecan 2 (92 % identity) and to a lesser degree those of rat syndecans 1, 3 and 4 (62, 64 and 78 % respectively). The putative N-terminal ectodomain contains a possible attachment site for heparan sulphate, identical with the comparable glycosaminoglycan-attachment sequence of rat
INTRODUCTION
The syndecans are a family of integral membrane cell-surface heparan sulphate proteoglycans. In mammals, four types of syndecan have been defined. Each is encoded by a unique gene (reviewed in ref. [1] ). A single syndecan, that of Drosophila, has been identified in non-vertebrate species [2] . The core proteins of all known syndecan types share similar domain structures: a cytoplasmic domain ranging from 28 to 35 amino acids depending on the particular syndecan, a transmembrane domain consisting of 25 amino acids and an extracellular domain (ectodomain) the size and composition of which differs in each of the syndecan types. The cytoplasmic and transmembrane domains of each syndecan type are very similar but the extracellular domains diverge in size and amino acid composition. Each of the extracellular domains has putative glycosaminoglycan (GAG)-attachment sites as well as a putative proteolytic-cleavage site near the junction of the ectodomain and transmembrane domains. Each syndecan is modified by one or more heparan sulphate side chains; syndecan 1 also contains a chondroitin sulphate side chain [1] .
Syndecans are capable of binding a variety of biological substrates involved in cell proliferation and differentiation. These include proteinase inhibitors [3] , extracellular matrix components [4] [5] [6] and heparin-binding growth factors such as basic fibroblast growth factor (bFGF) [7] [8] [9] [10] . The significance of syndecan binding to bFGF has been investigated in detail. The ability of bFGF to induce cell proliferation and differentiation depends on syndecan 2. Polyclonal antisera raised against recombinant ectodomain of XS-2, expressed as a fusion protein, recognized a heparan sulphate proteoglycan in XTC cell-culture medium. This proteoglycan bound to DEAE-Sephacel and was eluted with 1 M NaCl; digestion with heparitinase but not chondroitinase ABC resulted in the identification of a 46 kDa protein by these antisera. Northern-blot analysis indicated that XS-2 identifies two Xenopus mRNA species approx. 4 and 2 kb in size in embryos ranging in maturation from the 64-cell stage to stage 54. These results demonstrate that a heparan sulphate proteoglycan, similar to syndecan 2, is expressed during Xenopus embryogenesis.
specific binding to cell-surface heparan sulphate [8] . Binding of bFGF to heparan sulphate increases the affinity of bFGF for its cognate tyrosine kinase receptors [11] . Both syndecans 1 and 3 bind bFGF via their heparan sulphate side chains [7, 10] .
The spatial and cell-specific expression of syndecans during embryogenesis also suggests that these proteoglycans play a role in development. For example, syndecan 1 is expressed in an asymmetric pattern in cells and tissues during early embryogenesis. In the mouse embryo, syndecan 1 is expressed as early as the four-cell stage, and is present on the surface of the blastomeres principally at the sites of cell-cell contact. Later in development it is expressed on the basolateral surface of the primitive ectodermal cells and their derivatives, the endoderm and undifferentiated mesodermal cells emerging from the primitive streak. Syndecan-1 mesodermal expression then becomes asymmetric as it is lost from the anterior mesoderm but maintained in the posterior and lateral mesoderm [12] .
Syndecans are also expressed at critical periods during embryonic mesenchymal-epithelial interactions [13] . For example, in the mouse embryo at the onset of these interactions syndecan 1 is expressed by epithelial cells but not by mesenchymal cells. As development ensues, the epithelium undergoes a morphogenetic change and transiently loses its cell surface syndecan 1. Meanwhile, the mesenchymal cells proliferate, condense around the epithelium and express syndecan 1 de novo. The temporal and cell-specific expression of syndecans during these interactions suggests that they may be involved in interactions with growth factors, extracellular matrix molecules and adjacent cells. All of [14] . Expression of truncated bFGF receptor in the embryo results in major deficiencies of the lateral and posterior mesoderm [15] . bFGF may also modulate the inducing activity of activin, a member of the transforming growth factor , superfamily and a potent inducer of anterior and dorsal mesoderm [16] . The activity of both of these growth factors appears to be dose-dependent, suggesting that mechanisms that titrate the amount of these growth factors presented to cells in a temporally and spatially specific manner must exist within the embryo. In the Xenopus embryo, the expression of cell-surface heparan sulphate proteoglycans may serve as a mechanism by which local concentrations of growth factors such as activin and bFGF are modulated. Although proteoglycans such as the syndecans have not previously been described in Xenopus, the conservation of expression of many developmentally important genes across species [17] [19] . Developmental stages were determined as described by Nieuwkoop and Faber [20] . Embryos at defined stages were snap-frozen in liquid N2 and stored at -80°C. Total RNA was subsequently isolated by the lithium chloride method [21] . The Xenopus embryonic cell line, XTC, was maintained in tissue culture at 22°C in medium consisting of 70% Liebovitz L-15 medium (Gibco-BRL), 10% fetal bovine serum (Hyclone), 1 % Hepes, 1 % L-glutamine, penicillin (100 units/ml) and streptomycin (100 ,g/ml) [22] . Confluent cells were treated with trypsin, washed in PBS, snap-frozen in liquid N2 and stored at -80 'C. Poly(A)+ mRNA was subsequently isolated by the proteinase K method followed by binding to oligo(dT)-cellulose (Micro Fast Track; Invitrogen).
Northern-blot analysis RNA isolated from Xenopus embryos and embryonic cells was fractionated by electrophoresis in agarose gels in the presence of formaldehyde/formamide after which the RNA was transferred to nylon membranes (Durolon UV; Stratagene). The membranes were hybridized with 32P-labelled XS-2 under the conditions described above.
Construction of expression plasmlds and Isolation of the hybrid proteins A plasmid was constructed that expressed the ectodomain of XS-2 as a fusion protein with glutathione S-transferase (GST) [23] . A DNA fragment encoding 115 amino acids of the XS-2 extracellular domain (residues 18-132) was generated by PCR using a 5' sense primer, 5'-GCGGATCCGGGGAAACGTGG-GCCCAAGCT-3', including a BamHI site at the 5' end, and a 3' antisense primer, 5'-GCGAATTCTTATCTGTGGAACAGG-TTCTC-3', including the stop codon TAA and an EcoRI site at the 5' end. XS-2 was used as the substrate in the PCR under the conditions described above. The 364 bp amplification product was digested with BamHI and EcoRI and ligated to the expression plasmid pGEX-2T (Pharmacia), digested with the corresponding enzymes. Transformed DHSa cells were grown overnight at 37 'C on ampicillin plates. Colonies containing recombinant plasmids were detected by screening isolated plasmid DNA with 32P-labelled XS-2 and by identifying GST fusion proteins in SDS/polyacrylamide gels. DNA sequences were obtained at the BawnHI site of vector-insert recombination to confirml that the coding sequence of the insert was in frame.
Fusion proteins for immunization and for Western-blot PCR using flanking oligonucleotide primers encoding sequences analysis were isolated from exponentially growing cultures of transformed cells induced with 0.1 mM isopropyl f-D-thiogalactopyranoside. Fusion proteins were isolated by addition of glutathione-Sepharose 4B beads (Pharmacia) to the cell lysate, precipitation of beads by centrifugation and subsequent elution of the fusion proteins by competition with reduced glutathione [23] . The size of the eluted proteins was compared with that of the parental GST in Coomassie stained SDS/polyacrylamide gels.
Generation of polyclonal antl-XS-2 sera Purified pGEX-2T-XS-2-encoded fusion protein (200 ,tg) was mixed with an equal volume of complete Freund's adjuvant and injected intradermally into rabbits. Additional injections of 100, 50 and 20 ,g of fusion proteins in incomplete Freund's adjuvant were performed subcutaneously at 28, 42 and 56 days respectively. Immune sera were obtained from ear bleedings and were tested on dot-blots of fusion proteins. The fusion-protein bands were detected in immunoblots at a dilution of 1: 500-1:7500 with minimal background. Preimmune sera showed no reactivity.
Isolation and analysis of Xenopus proteoglycans
Proteoglycans were isolated from conditioned medium of Xenopus XTC cells (kindly provided by Dr. L. Zon, Children's Hospital, Boston, MA, U.S.A.) using a modification ofpreviously published procedures [4] . Cell-culture medium was harvested 96 h after addition to XTC cultures. It was then prepared for proteoglycan extraction by adding urea and Triton X-100 to achieve final concentrations of 2 M and 0.1 % respectively and acidifying to pH 4.5 with acetic acid. DEAE-Sephacel (Pharmacia), equilibrated with column wash buffer (0.2 M NaCl, 2 M urea, 50 mM sodium acetate, pH 4.5, and 0.1 % Triton X-100), was added to the conditioned medium in a ratio of 1: 75 (v/v) and incubated with gentle rocking for 16 h at 4 'C. The DEAESephacel/conditioned medium mix was then loaded on to a column, washed with 10 bed vol. ofcolumn wash buffer and then 10 bed vol. of column wash buffer without urea. Material bound to the column was eluted in 3 bed vol. of a buffer containing 1 M NaCl, 0.1 % Triton X-100 and 50 mM sodium acetate, pH 4 glycine and 20% methanol for 2 h at 400 mA. Membranes derived from dot-blotting of XTC proteoglycans or electrotransfer of electrophoresed proteins were blocked with 5 % nonfat dry milk in PBS containing 0.02 % NaN3 overnight and then incubated with primary antibody for 1 h followed by a secondary antibody conjugated to alkaline phosphatase. Protein bands reactive with antibody were detected by a colour reaction using substrates for alkaline phosphatase supplied in a commercial kit (Protoblot Immunoscreening System; Promega Biotec).
RESULTS

XS-2 encodes a putative Integral membrane cell-surface protoglycan
The members ofthe syndecan family ofcell-surface proteoglycans are strikingly similar in their transmembrane and cytoplasmic domains [1] . These similarities are maintained across species including human, rat, mouse and chicken. In contrast, the extracellular domains are dissimilar except for the sequences that encode putative sites for substitution with GAG chains. Given that the transmembrane and cytoplasmic sequences are highly specific for the syndecans, we used a DNA probe containing these sequences to screen for expression of syndecan family members during Xenopus development. Screening of a Xenopus embryonic stage-22-24 cDNA library with the mouse DNA probe encoding the transmembrane and cytoplasmic domains of syndecan 1 resulted in the identification of a single recombinant which contained a 1389 bp cDNA insert (Figure 1 ). The first ATG within this open reading frame occurs at position 459. This ATG is preceded by guanosine residues at positions -9 to -4 and + 4 and + 5, providing a favourable context for the initiation of translation [24] . The ATG at position 459 is the start of a 573 bp coding sequence encoding a 191-amino acid (20843 Da) protein product. Two canonical polyadenylation signals (AATAA) are contained within the 3' region of the cDNA (positions 1237 and 1279). Notably, neither of these is followed by a poly(dA) stretch, suggesting that there is more 3' sequence not contained within the cDNA.
Analysis of the hydropathy characteristics of the derived XS-2 translation product suggests that the protein consists of distinct hydrophilic and hydrophobic domains (Figure 2 ). The Kyte-Doolittle hydropathy analysis [25] indicates that the first 18 amino acids after the translation start form a hydrophobic domain. The composition of this peptide is compatible with that of a signal peptide. This hydrophobic domain is followed by a 116-amino acid hydrophilic domain extending from position 19 to residue 134. This domain contains numerous putative glycosylation sites (see below). The presence of these putative glycosylation and protease-cleavage sites in the context of the other putative domains suggest that this domain is an extracellular domain (ectodomain). Further toward the carboxyl end of the protein is a 25-amino acid hydrophobic region with the size and amino acid composition of known transmembrane domains. Finally, the coding sequence concludes with a 32-amino acid hydrophilic domain that contains three tyrosine residues. The position of these residues is conserved in the cytoplasmic domains of other cell-surface integral membrane proteoglycans (syndecans) [1] . Their function is unknown but they have been implicated in the targeting of integral membrane proteins to specific membrane domains and endocytic compartments [26] . The 
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S T 781 c t aac ac a g t c t t g t c t ac gg aa a gaa g ga t a t c gt cc ag a ct g c gac ac ac a c a ga ga (Figure 4 ). In this region XS-2 sequences were nearly identical with those in syndecan 2 [29] , serglycin [31] and CD44 [32] , each a proteoglycan. These similarities emphasize the probable identity of XS-2 as a proteoglycan. 
XS-2 codes for a core protein linked to heparan sulphate
To identify the translation product of the XS-2 gene, a DNA construct encoding the ectodomain of XS-2 was expressed as a fusion protein with GST. The ectodomain was chosen because the sequences contained within it are found in a limited number of proteins (Figure 4 ). High-titre rabbit polyclonal antisera were generated against this fusion protein and used to study the XS-2 translational product. The observation that XS-2 mRNA is expressed by the Xenopus embryonic cell line, XTC, provided the basis for studying the proteins/proteoglycans expressed by these cells (Figure 7, below) . Initial analysis of proteoglycans isolated from XTC culture medium by dot-blot assay indicated that the antisera identified material which bound to DEAE-Sephacel and was eluted under conditions of high salt concentration (1 M NaCl ( Figure 5 ). This suggested that the antisera recognizes a proteoglycan. Amino acid sequences in the ectodomain of XS-2 were analysed by comparing them with known sequences in the Brookhaven Protein Data Bank, Genbank and the EMBL Data Bank using the BLAST program. Results indicate significant similarity (P < 0.01) between a 12-amino acid region in the XS-2 ectodomain and the putative GAG-attachment sites found within the heparan sulphate proteoglycans, rat syndecan 2, serglycin [31 ] and CD44 [32] . Amino acid residues that differ between these sequences are presented in plain type. The potential XS-2 GAGattachment sequence between amino acid residues 42 and 53 shows the sequence Ser-Gly-SerGly with acidic residues N-terminal to the serine. This sequence is in agreement with the consensus sequence described by Bourdon et al. [27] .
A B C D E Figure 5 Dot-blot analysis of secreted XTC products chromatographed against DEAE-Sephaeel Secreted XTC cell products chromatographed against DEAE-Sephacel and eluted in 1 M NaCI buffer were bound to positively charged nylon membranes (Biodyne; BRL-Gibco) using a dotblot apparatus (BRL-Gibco) and incubated with a polyclonal antiserum raised against recombinant XS-2 ectodomain expressed as a bacterial fusion protein. A, 1 ,ug of fusion protein incubated with preimmune serum; B, 1 jug of fusion protein incubated with XS-2 polyclonal antiserum; C, 0.2 M NaCI/6 M urea wash of DEAE-Sephacel column exposed beforehand to XTC-secreted products; D, 0.2 M NaCI wash of DEAE-Sephacel column exposed beforehand to XTC-secreted products; E, 1 M NaCI elulate of XTC-secreted products previously bound to DEAE-Sephacel.
To analyse further the material identified by the antisera, the material that eluted from DEAE-Sephacel in 1 M NaCl was separated by SDS/PAGE and transferred to a positively charged membrane. The undigested proteoglycan did not enter the 12 % polyacrylamide gel used to identify low-molecular-mass proteins ofthe size predicted for the XS-2 core protein (21 kDa). However, digestion with the heparitinase before electrophoresis resulted in The amino acid sequences of the putative transmembrane and cytoplasmic domains of XS-2 are compared with sequences contained within the comparable domains of rat syndecan 2, rat syndecan 4, rat syndecan 3 and rat syndecan 1. Amino acid residues, presented in outline form, are conserved among all these proteins with respect to their position within their respective domains and their chemical characteristics (charge and philicity). Amino acid residues presented in plain type are not conserved by these criteria. Spaces have been inserted between amino acid sequences to generate the greatest degree of alignment for this analysis. 
DISCUSSION
The studies described in this report indicate that a cell-surface integral membrane heparan sulphate proteoglycan is expressed in the Xenopus embryo. The derived domain structure of the cDNA, XS-2, is highly suggestive of a core protein which consists of an extracellular domain containing GAG-attachment sites, a transmembrane domain and a cytoplasmic domain. The sequence similarity between the XS-2 transmembrane and cytoplasmic domains to those of the four mammalian syndecans provides compelling evidence that XS-2 is a syndecan and, more specifically, is the Xenopus counterpart of syndecan 2. The XS-2 transmembrane and cytoplasmic domains are 92 % identical with those of rat syndecan 2 (rat fibroglycan) (Figure 3) . The relatedness of XS-2 to syndecan 2 is further emphasized by the similarity between their putative GAG-attachment sites ( Figure  4 ). The lack of similarity ofthe remainder of the XS-2 ectodomain to that of mammalian syndecans [1] [2] [3] [4] and Drosophila syndecan is characteristic of the syndecan family. Whereas the cytoplasmic and transmembrane domains of all four mammalian types are highly conserved, the ectodomains diverge between family members except near their N-termini where each shows a cluster of GAG-attachment sites of the general form Ser-Gly-(Xaa)fSer-Gly-Ser-Gly [1] , as does XS-2.
Evidence that the mature XS-2 translation product is a proteoglycan was obtained using polyclonal antiserum generated against the recombinant XS-2 ectodomain. This antiserum identifies a fraction of secreted XTC cell products which bind to DEAE-Sephacel under low-salt (0.2 M NaCl) conditions and which are eluted in high-salt (1 M NaCl) buffer. This fraction could not be detected in high-percentage polyacrylamide gels unless it was treated with heparitinase; a specific protein band of 46 kDa was then identified with the antiserum. In contrast, no reactive protein could be detected after digestion with chrondoitinase ABC. These results indicate that the mature XS-2 translation product is a heparan sulphate proteoglycan. These results are also compatible with the presence of a sequence motif in the putative XS-2 ectodomain that closely resembles the SerGly repeat and flanking sequences of other known heparan sulphate proteoglycans (rat syndecan 2, serglycin and CD44).
The XS-2 cDNA sequence predicts that the XS-2 translation product is approx. 21 kDa in size. This is identical with the predicted syndecan-2 protein product as cloned from rat liver [29] . However, the anti-XS-2 serum detected an approx. 46 kDa protein after digestion of the DEAE-Sephacel-bound fraction with heparitinase. A similar discrepancy in the size on SDS/PAGE of the syndecan-2 core protein isolated from rat liver plasma membranes has been reported [29] . Several [20] . Although murine syndecan 1 is similarly expressed in the early blastula, it is expressed as a zygotic not a maternal transcript [12] . More fundamental differences may exist between the expression of XS-2 and mouse syndecan 2. In contrast with XS-2 mRNA, the mouse syndecan-2 core protein is only detectable relatively late in embryogenesis, during organogenesis [33] . This suggests that whereas both XS-2 and mouse syndecan 2 may have a role in organogenesis, XS-2 may also be involved in earlier developmental processes, occurring in the blastula and gastrula. Further analysis of these potential differences between XS-2 and mouse syndecan-2 expression will depend on the study of mouse syndecan-2 mRNA expression and XS-2 core protein expression during embryogenesis.
From [8] . Secondly, both XS-2 and bFGF are expressed in the Xenopus blastula and gastrula [14, 15] . Finally, heparitinase treatment to degrade heparan sulphate proteoglycans in the early blastula blocks normal mesodermal development and treatment ofanimal caps with heparitinase blocks normal responsiveness to induction to bFGF [35] . Several cell-surface heparan sulphate proteoglycans may be expressed during early Xenopus development; our studies suggest that XS-2 is one of them. Future studies aimed at determining the spatial distribution of XS-2 as well as that of growth factors such as bFGF will help to elucidate further the role of XS-2 during Xenopus development.
